Alnylam Pharmaceuticals (ALNY) Shares Issued (2016 - 2025)
Historic Shares Issued for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q3 2025 value amounting to $77.7 million.
- Alnylam Pharmaceuticals' Shares Issued fell 2804.25% to $77.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $244.6 million, marking a year-over-year decrease of 1779.83%. This contributed to the annual value of $303.0 million for FY2024, which is 10544.06% up from last year.
- Latest data reveals that Alnylam Pharmaceuticals reported Shares Issued of $77.7 million as of Q3 2025, which was down 2804.25% from $81.2 million recorded in Q2 2025.
- Alnylam Pharmaceuticals' Shares Issued's 5-year high stood at $153.0 million during Q3 2022, with a 5-year trough of $22.5 million in Q2 2022.
- For the 5-year period, Alnylam Pharmaceuticals' Shares Issued averaged around $61.3 million, with its median value being $49.4 million (2025).
- Its Shares Issued has fluctuated over the past 5 years, first tumbled by 8378.97% in 2023, then skyrocketed by 33554.12% in 2024.
- Alnylam Pharmaceuticals' Shares Issued (Quarter) stood at $45.0 million in 2021, then grew by 25.92% to $56.7 million in 2022, then tumbled by 45.53% to $30.9 million in 2023, then grew by 17.43% to $36.3 million in 2024, then skyrocketed by 114.29% to $77.7 million in 2025.
- Its Shares Issued stands at $77.7 million for Q3 2025, versus $81.2 million for Q2 2025 and $49.4 million for Q1 2025.